OrbiMed’s Crinetics Pharmaceuticals CRNX Stock Holding History

OrbiMed’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.3M	Hold	999,000	–	–	0.79%	41
2025 Q4	$46.5M	Sell	999,000 -100,000	-9%	-$4.45M	0.95%	31
2025 Q3	$45.8M	Sell	1,099,000 -50,000	-4%	-$1.6M	1.1%	32
2025 Q2	$33M	Buy	1,149,000 +150,000	+15%	+$4.63M	0.83%	30
2025 Q1	$33.5M	Hold	999,000	–	–	0.8%	35
2024 Q4	$51.1M	Sell	999,000 -51,055	-5%	-$2.86M	1.06%	28
2024 Q3	$53.7M	Sell	1,050,055 -230,745	-18%	-$11.9M	0.98%	30
2024 Q2	$57.4M	Sell	1,280,800 -104,200	-8%	-$4.81M	1.14%	27
2024 Q1	$64.8M	Sell	1,385,000 -282,360	-17%	-$11M	1.19%	27
2023 Q4	$59.3M	Sell	1,667,360 -1,228,714	-42%	-$37.7M	1.19%	31
2023 Q3	$86.1M	Sell	2,896,074 -1,054,722	-27%	-$21.7M	1.85%	14
2023 Q2	$71.2M	Hold	3,950,796	–	–	1.3%	28
2023 Q1	$63.4M	Buy	3,950,796 +753,920	+24%	+$14M	1.26%	24
2022 Q4	$58.5M	Hold	3,196,876	–	–	1.12%	33
2022 Q3	$62.8K	Hold	3,196,876	–	–	1.17%	30
2022 Q2	$59.6K	Hold	3,196,876	–	–	1.08%	30
2022 Q1	$70.2M	Hold	3,196,876	–	–	1.14%	31
2021 Q4	$90.8M	Buy	3,196,876 +200,000	+7%	+$4.93M	1.17%	31
2021 Q3	$63.1M	Hold	2,996,876	–	–	0.69%	46
2021 Q2	$56.5M	Buy	2,996,876 +243,309	+9%	+$4.28M	0.57%	51
2021 Q1	$42.1M	Hold	2,753,567	–	–	0.39%	69
2020 Q4	$38.9M	Hold	2,753,567	–	–	0.34%	70
2020 Q3	$43.1M	Hold	2,753,567	–	–	0.55%	56
2020 Q2	$48.2M	Buy	2,753,567 +714,285	+35%	+$12.2M	0.68%	46
2020 Q1	$30M	Hold	2,039,282	–	–	0.51%	54
2019 Q4	$51.2M	Hold	2,039,282	–	–	0.73%	44
2019 Q3	$30.7M	Hold	2,039,282	–	–	0.59%	49
2019 Q2	$51M	Buy	2,039,282 +125,000	+7%	+$3.1M	0.8%	39
2019 Q1	$43.6M	Hold	1,914,282	–	–	0.68%	43
2018 Q4	$57.4M	Hold	1,914,282	–	–	1.07%	30
2018 Q3	$54.8M	Buy	+1,914,282	New	+$56.8M	0.66%	44

Other funds holding CRNX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return